Bortezomib-d8 is the deuterium-labeled (d8) isotopologue of bortezomib, a reversible and selective 20S proteasome inhibitor used in research on proteasome function, apoptosis, and multiple myeloma. It is supplied as a high-purity analytical reagent for use in mass spectrometry, tracer studies, and mechanistic experiments.
- Deuterium-labeled analogue for use as an internal standard.
- High purity suitable for analytical applications.
- Optimized for mass spectrometry and quantitative assays.
- Small package size for low-quantity, high-value experiments.
- Stable isotope labeling aids in accurate tracer and mechanistic studies.